Literature DB >> 25737199

The impact of immunomodulator compound from the group of substituted thiadiazines on the course of stress reaction.

P A Sarapultsev1, O N Chupakhin2, S U Medvedeva3, E A Mukhlynina3, S A Brilliant1, L P Sidorova4, I G Danilova3, A P Sarapultsev5.   

Abstract

A significant role of the stress response to many different diseases prompted a search for new specialized and non-specialized anti-stress agents. This study examines the effect of the compound L17 from the group of 5-phenyl substituted-6H-1,3,4-thiadiazine-2-amines, on the manifestations of the stress response. The authors used a standard model of immobilization stress, in which an animal was immobilized on its back for 6h a day. Parameters of the morphological and functional states of the organs studied were measured and biochemical and enzyme-immunoassays were carried out on the first and second days. This study reveals that the main mechanism by which the L17 compound mediates of its anti-stress was by activation of macrophages on the second day of the experiments and the inhibition of apoptosis in the thymus. The results enable us to suggest that the compound L17 does not improve resistance to stress; however, it does lower the reaction to stress.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  6H-1,3,4-Thiadiazine; Anti-stress agents; L-17 compound; Stress; Thiadiazines

Mesh:

Substances:

Year:  2015        PMID: 25737199     DOI: 10.1016/j.intimp.2015.02.024

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  2 in total

1.  Pharmacologic Evaluation of Antidepressant Activity and Synthesis of 2-Morpholino-5-phenyl-6H-1,3,4-thiadiazine Hydrobromide.

Authors:  Alexey P Sarapultsev; Oleg N Chupakhin; Petr A Sarapultsev; Larisa P Sidorova; Tatiana A Tseitler
Journal:  Pharmaceuticals (Basel)       Date:  2016-05-19

Review 2.  Immunomodulatory Action of Substituted 1,3,4-Thiadiazines on the Course of Myocardial Infarction.

Authors:  Alexey P Sarapultsev; Pavel M Vassiliev; Petr A Sarapultsev; Oleg N Chupakhin; Laura R Ianalieva; Larisa P Sidorova
Journal:  Molecules       Date:  2018-07-02       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.